Department of Orthopaedics and Traumatology, Veterans General Hospital, Taipei, Taiwan.
Acta Orthop. 2011 Aug;82(4):460-4. doi: 10.3109/17453674.2011.581266.
The result of treatment of infections involving antibiotic-resistant organisms in total knee arthroplasty (TKA) is often poor. We evaluated the efficacy of 2-stage revision in TKAs infected with resistant organisms and compared the clinical outcomes with articulating and conventional static spacers, in terms of both infection control and function.
In a prospective manner, from June 2003 to January 2007 selected patients with a TKA infected with resistant organisms were enrolled and treated with 2-stage re-implantation. The 45 patients were divided into 2 groups: group A (23 patients) implanted with the articulating spacers and group S (22 patients) implanted with static spacers. All patients followed the same antibiotic protocols and had the same re-implantation criteria. The efficacy of infection control was evaluated using re-implantation rate, recurrence rate, and overall success rate. The functional and radiographic results were interpreted with the Hospital of Special Surgery (HSS) knee score and the Insall-Salvati ratio.
With mean 40 (24-61) months of follow-up, 22 of 23 knees were re-implanted in group A and 21 of 22 were re-implanted in group S. Of these re-implanted prostheses, 1 re-infection occurred in group A and 2 occurred in group S. Range of motion after re-implantation, the final functional scores, and the satisfaction rate were better in group A. One third of the patients in group S, and none in group A, had a patella baja.
After 2-stage re-implantation of TKAs originally infected with resistant organisms, the clinical outcome was satisfactory-and similar to that reported after treatment of TKAs infected with low-virulence strains. Treatment with an articulating spacer resulted in better functional outcome and lower incidence of patella baja.
全膝关节置换术(TKA)中感染抗生素耐药菌的治疗结果通常较差。我们评估了 2 期翻修在 TKA 感染耐药菌中的疗效,并比较了关节式和传统静态间隔器在感染控制和功能方面的临床结果。
前瞻性地从 2003 年 6 月至 2007 年 1 月,选择 TKA 感染耐药菌的患者进行 2 期再植入。45 例患者分为 2 组:A 组(23 例)植入关节式间隔器,S 组(22 例)植入静态间隔器。所有患者均遵循相同的抗生素方案和相同的再植入标准。感染控制的疗效通过再植入率、复发率和总成功率来评估。功能和影像学结果采用特种外科医院(HSS)膝关节评分和 Insall-Salvati 比值进行解释。
平均随访 40(24-61)个月,A 组 23 膝中有 22 膝再植入,S 组 22 膝中有 21 膝再植入。这些再植入的假体中,A 组有 1 例再感染,S 组有 2 例再感染。再植入后的活动范围、最终功能评分和满意度在 A 组更好。S 组中有三分之一的患者出现髌骨低位,而 A 组中没有患者出现髌骨低位。
在最初感染耐药菌的 TKA 进行 2 期翻修后,临床结果令人满意,与治疗低毒力菌株感染的 TKA 报告的结果相似。使用关节式间隔器治疗可获得更好的功能结果和更低的髌骨低位发生率。